Fennec Return On Equity from 2010 to 2024
| FENC Stock | USD 9.09 0.09 0.98% |
Return On Equity | First Reported 2010-12-31 | Previous Quarter 1.41311933 | Current Value 1.48 | Quarterly Volatility 13.32192699 |
Check Fennec Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Fennec main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Depreciation And Amortization of 436.6 K or Interest Expense of 3.6 M, as well as many exotic indicators such as Price To Sales Ratio of 13.09, Dividend Yield of 0.0 or Days Sales Outstanding of 140. Fennec financial statements analysis is a perfect complement when working with Fennec Pharmaceuticals Valuation or Volatility modules.
Fennec | Return On Equity |
Latest Fennec Pharmaceuticals' Return On Equity Growth Pattern
Below is the plot of the Return On Equity of Fennec Pharmaceuticals over the last few years. Return on Equity is the amount of Fennec Pharmaceuticals net income returned as a percentage of Fennec Pharmaceuticals equity. Return on equity measures Fennec Pharmaceuticals profitability by revealing how much profit Fennec Pharmaceuticals generates with the money shareholders have invested. It is a measure of the profitability of a business in relation to the equity, calculated by dividing net income by shareholder's equity. Fennec Pharmaceuticals' Return On Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Fennec Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported -10.06 | 10 Years Trend |
|
Return On Equity |
| Timeline |
Fennec Return On Equity Regression Statistics
| Arithmetic Mean | (4.66) | |
| Coefficient Of Variation | (285.80) | |
| Mean Deviation | 8.52 | |
| Median | (0.78) | |
| Standard Deviation | 13.32 | |
| Sample Variance | 177.47 | |
| Range | 48.7104 | |
| R-Value | 0.65 | |
| Mean Square Error | 109.36 | |
| R-Squared | 0.43 | |
| Significance | 0.01 | |
| Slope | 1.95 | |
| Total Sum of Squares | 2,485 |
Fennec Return On Equity History
About Fennec Pharmaceuticals Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Fennec Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Fennec Pharmaceuticals investors use historical funamental indicators, such as Fennec Pharmaceuticals's Return On Equity, to determine how well the company is positioned to perform in the future. Although Fennec Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Fennec Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Fennec Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Fennec Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Fennec Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Equity | 1.41 | 1.48 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Fennec Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Fennec Pharmaceuticals' short interest history, or implied volatility extrapolated from Fennec Pharmaceuticals options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Fennec Pharmaceuticals Correlation against competitors. For information on how to trade Fennec Stock refer to our How to Trade Fennec Stock guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Complementary Tools for Fennec Stock analysis
When running Fennec Pharmaceuticals' price analysis, check to measure Fennec Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fennec Pharmaceuticals is operating at the current time. Most of Fennec Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Fennec Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fennec Pharmaceuticals' price. Additionally, you may evaluate how the addition of Fennec Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Stocks Directory Find actively traded stocks across global markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |
Is Fennec Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fennec Pharmaceuticals. If investors know Fennec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fennec Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.60) | Revenue Per Share 0.8 | Quarterly Revenue Growth 5.342 | Return On Assets (0.30) | Return On Equity (10.06) |
The market value of Fennec Pharmaceuticals is measured differently than its book value, which is the value of Fennec that is recorded on the company's balance sheet. Investors also form their own opinion of Fennec Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Fennec Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fennec Pharmaceuticals' market value can be influenced by many factors that don't directly affect Fennec Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fennec Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fennec Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fennec Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.